Research & development > Clinical diagnostics

Qiagen QuantiFERON Monitor for tracking immune function in solid organ transplant patients

29 January, 2015

Qiagen has announced the QuantiFERON Monitor (QFM), a novel diagnostic for monitoring immune function. It is available in non-European markets for research use as an accurate marker of immune function in studies of immunosuppressive conditions, immune modulating therapies and recovery following transplantation.

Why do young people have strokes?

28 January, 2015

Researchers from The Centenary Institute, Sydney, have announced a breakthrough in understanding the cause of stroke in young people. The leader of the research, Dr Xiangjian Zheng, said the stroke in question affects around five in every 1000 people, many of whom are diagnosed in their 30s and 40s.

Regulatory registration of Qiagen lung cancer companion diagnostic

14 January, 2015

Qiagen has announced the CE-IVD marking of its liquid biopsy-based companion diagnostic that analyses circulating nucleic acids obtained from blood samples to assess a genomic mutation in patients with non-small cell lung cancer (NSCLC).

Identification of a pre-cancerous state in the blood

10 December, 2014

US researchers have uncovered a 'pre-malignant' state in the blood that significantly increases the likelihood that an individual will develop blood cancers such as leukaemia, lymphoma or myelodysplastic syndrome.

Low-cost technique to detect rotavirus

08 October, 2014

Researchers at the Universidad Politécnica de Madrid (UPM) have found a new, low-cost way to enhance detection capacity of small concentrations of rotavirus - a sphere-shaped virus up to 75 nm in diameter that has the appearance of a wheel, seen from an electron microscope.

The molecular details of coeliac disease

01 May, 2014

Australian, US and Dutch researchers have determined the molecular details of the interaction between the immune system and gluten that triggers coeliac disease.

Starpharma tech applied to AstraZeneca cancer drug

08 April, 2014

Melbourne-based biotech company Starpharma has signed an expanded agreement with biopharma company AstraZeneca in the field of cancer medicine. The new agreement will see the application of Starpharma's dendrimer technology to a cancer drug from AstraZeneca's pipeline.

Diagnostic device meets malaria field evaluation objective

25 March, 2014

Fio Corporation's Deki Reader - a mobile in vitro diagnostic device - has demonstrated consistent interpretation of rapid diagnostic tests (RDTs) for multiple malaria strains in a field evaluation.

Turning the spotlight on breast cancer cells

20 March, 2014

Scientists are using the latest in nano-flare technology to detect breast cancer cells early on.

Drug testing with synthetic livers

19 March, 2014

Scientists from clinical intelligence company Empiriko have developed chemosynthetic liver technology which could enable the testing of drug candidates without using animals.

Biomarkers reveal short-term risk of death

05 March, 2014

Researchers from Finland and Estonia have discovered novel biological markers that indicate an individual's risk of dying from any disease in the near future.

Successful phase 2 results in Huntington disease trial

24 February, 2014

Prana Biotechnology has announced the results of its phase 2 clinical trial investigating the drug PBT2 as a treatment for Huntington disease.

€85 million to fight Gram-negative pathogens

13 February, 2014

Over 30 European universities, research institutes and companies are joining forces in a six-year, €85 million program to develop novel antibiotics against Gram-negative pathogens.

What killed Knut, Berlin Zoo's polar bear?

07 February, 2014

After one of the most intensive investigations in veterinary history for a single animal, what caused the death of Berlin Zoological Garden's polar bear, Knut, has been revealed.

Developing single-dose vaccines for cattle

06 February, 2014

Researchers at The University of Queensland (UQ) are working on a single-dose (shelf-stable) vaccine that could be used to prevent common cattle diseases and reduce vaccination costs.

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd